Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A De Man

Showing results (211-220 of 543) with videos related to

Pageof 55
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|February 24, 1999
[Hepatocellular adenoma in 20 patients; recommendations for treatment]J H de Wilt, R A de Man, J S Laméris, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 13, 2001
[Cyanosis and liver cirrhosis: hepatopulmonary syndrome]K van der Linde, P T van Hal, H Stam, et al.
Digestive Surgery|November 4, 2004
Good outcomes after resection of large hepatocellular carcinoma in the non-cirrhotic liverC Verhoef, R A de Man, P E Zondervan, et al.
Arthritis and Rheumatism|May 29, 2007
Measuring disease activity and functionality during pregnancy in patients with rheumatoid arthritisYaël A de Man, Johanna M W Hazes, Fleur E van de Geijn, et al.
Gastroenterology|November 1, 1992
Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liverF E de Jongh, H L Janssen, R A de Man, et al.
Hepatology (Baltimore, Md.)|June 26, 2022
Fatty liver disease is not associated with increased mortality in the elderly: A prospective cohort studyLaurens A van Kleef, Milan J Sonneveld, Maryam Kavousi, et al.
Family Practice|July 23, 2022
Epidemiology and management of hepatitis B and C in primary care in the Netherlands: data from the Rijnmond Primary Care databaseSylvia M Brakenhoff, Robert A de Man, Robert J de Knegt, et al.
Plos One|July 18, 2014
The predictive value of Golgi protein 73 in differentiating benign from malignant liver tumorsMirelle E E Bröker, Jan N M Ijzermans, Caroline D M Witjes, et al.
Scientific Reports|February 21, 2024
Cryptogenic non-cirrhotic HCC: Clinical, prognostic and immunologic aspects of an emerging HCC etiologyBoris J B Beudeker, Rael Guha, Kalina Stoyanova, et al.
Liver|June 26, 2001
Efficacy and safety of an intravenous monoclonal anti-HBs in chronic hepatitis B patientsA B van Nunen, M Baumann, M P Manns, et al.
Pageof 55

Showing results (211-220 of 543) with videos related to

Sort By:
Pageof 55
Nederlands Tijdschrift Voor Geneeskunde|February 24, 1999
[Hepatocellular adenoma in 20 patients; recommendations for treatment]J H de Wilt, R A de Man, J S Laméris, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 13, 2001
[Cyanosis and liver cirrhosis: hepatopulmonary syndrome]K van der Linde, P T van Hal, H Stam, et al.
Digestive Surgery|November 4, 2004
Good outcomes after resection of large hepatocellular carcinoma in the non-cirrhotic liverC Verhoef, R A de Man, P E Zondervan, et al.
Arthritis and Rheumatism|May 29, 2007
Measuring disease activity and functionality during pregnancy in patients with rheumatoid arthritisYaël A de Man, Johanna M W Hazes, Fleur E van de Geijn, et al.
Gastroenterology|November 1, 1992
Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liverF E de Jongh, H L Janssen, R A de Man, et al.
Hepatology (Baltimore, Md.)|June 26, 2022
Fatty liver disease is not associated with increased mortality in the elderly: A prospective cohort studyLaurens A van Kleef, Milan J Sonneveld, Maryam Kavousi, et al.
Family Practice|July 23, 2022
Epidemiology and management of hepatitis B and C in primary care in the Netherlands: data from the Rijnmond Primary Care databaseSylvia M Brakenhoff, Robert A de Man, Robert J de Knegt, et al.
Plos One|July 18, 2014
The predictive value of Golgi protein 73 in differentiating benign from malignant liver tumorsMirelle E E Bröker, Jan N M Ijzermans, Caroline D M Witjes, et al.
Scientific Reports|February 21, 2024
Cryptogenic non-cirrhotic HCC: Clinical, prognostic and immunologic aspects of an emerging HCC etiologyBoris J B Beudeker, Rael Guha, Kalina Stoyanova, et al.
Liver|June 26, 2001
Efficacy and safety of an intravenous monoclonal anti-HBs in chronic hepatitis B patientsA B van Nunen, M Baumann, M P Manns, et al.
Pageof 55